Cellectar Biosciences, Inc. (CLRB)
2.40
-0.01
(-0.41%)
USD |
NASDAQ |
Sep 09, 12:39
Cellectar Biosciences Market Cap : 19.81M for Sept. 9, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 08, 2026 | 19.89M |
| September 04, 2026 | 19.56M |
| September 03, 2026 | 19.39M |
| September 02, 2026 | 20.05M |
| September 01, 2026 | 20.30M |
| August 31, 2026 | 20.71M |
| August 28, 2026 | 20.88M |
| August 27, 2026 | 20.96M |
| August 26, 2026 | 20.96M |
| August 25, 2026 | 20.96M |
| August 24, 2026 | 20.80M |
| August 21, 2026 | 21.37M |
| August 20, 2026 | 21.37M |
| August 19, 2026 | 21.62M |
| August 18, 2026 | 21.37M |
| August 17, 2026 | 21.13M |
| August 14, 2026 | 21.46M |
| August 13, 2026 | 20.47M |
| August 12, 2026 | 21.46M |
| August 11, 2026 | 21.79M |
| August 10, 2026 | 21.46M |
| August 07, 2026 | 10.90M |
| August 06, 2026 | 10.69M |
| August 05, 2026 | 10.69M |
| August 04, 2026 | 10.85M |
| Date | Value |
|---|---|
| August 03, 2026 | 11.28M |
| July 31, 2026 | 10.90M |
| July 30, 2026 | 10.73M |
| July 29, 2026 | 10.52M |
| July 28, 2026 | 10.60M |
| July 27, 2026 | 10.26M |
| July 24, 2026 | 10.22M |
| July 23, 2026 | 10.47M |
| July 22, 2026 | 10.47M |
| July 21, 2026 | 10.94M |
| July 20, 2026 | 10.69M |
| July 17, 2026 | 10.64M |
| July 16, 2026 | 10.94M |
| July 15, 2026 | 11.07M |
| July 14, 2026 | 11.15M |
| July 13, 2026 | 11.15M |
| July 10, 2026 | 11.96M |
| July 09, 2026 | 11.75M |
| July 08, 2026 | 11.41M |
| July 07, 2026 | 11.45M |
| July 06, 2026 | 11.75M |
| July 02, 2026 | 11.91M |
| July 01, 2026 | 12.00M |
| June 30, 2026 | 11.79M |
| June 29, 2026 | 11.02M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 4.773B |
| Alnylam Pharmaceuticals, Inc. | 34.20B |
| Anika Therapeutics, Inc. | 280.51M |
| Savara, Inc. | 1.105B |
| Vericel Corp. | 1.986B |
Market Cap Related Metrics
| Price to Book Value | 0.6630 |
| Price | 2.40 |
| Earnings Yield | -189.8% |